Achim Schlapbach
0000-0001-8137-8889
Novartis Institutes for BioMedical Research Basel
1 paper found
Refreshing results…
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient
Missing publications? Search for publications with a matching author name.